Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Price index for reimbursable medicines in France 1998-2015

Consumer price index (CPI) of medicines reimbursable in France from 1998 to 2015 *

by Statista Research Department, last edited Sep 5, 2016
Price index for reimbursable medicines in France 1998-2015 This statistic shows the evolution of the consumer price index for reimbursable medicines in France from 1998 to 2015. This shows that the consumer price index for reimbursable medicines was at its lowest in 2015 at around 63.
Show more

Consumer price index (CPI) of medicines reimbursable in France from 1998 to 2015 *

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Asthma prevalence in the United Kingdom"
  • Overview
The most important statistics
  • Medication
  • Hospital admissions
  • Occupational Asthma
  • Impairment
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.